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aBstRaCt
Background: Myelodysplasia has been reported to occur quite frequently in the spectrum 
of hiV/aids disease and is thought to be partly responsible for bone marrow failure 
in these patients.  however, the frequency and type of myelodysplasia appear to 
differ at different stages of the disease in different populations with mechanisms of 
its development not well understood.
Objective: to document the pattern of myelodysplasia in Ugandan patients with 
terminal hiV/aids disease.
Design: prospective descriptive study.
Setting: department of pathology, Faculty of Medicine, Makerere University College 
of health sciences
Subjects: Bone marrow necropsies from patients who died with aids disease at Mulago 
teaching hospital in Kampala, Uganda during a one-year period. 
Results: eighty-four (84%) of the 50 cases studied had myelodysplasia with 39 cases 
having megakaryocytic myelodysplasia.   Myelodysplasia involving erythroid cell 
series occurred in 23 and in 20 of these cases was in combination with megakaryocytic 
dysplasia.  granulocyte myelodysplastic features were observed in only two cases and 
these two cases did not have other cell lines involved.  
Conclusion: Myelodysplastic features are common in hiV patients with megakaryocytic 
and eythroid cell lines being the most affected. this could be due to the direct hiV  
effect, or the combined effect of opportunistic infections, neoplasms, drugs and hiV 
itself affecting the haemopoietic stem cell and or its microenvironment.
intRodUCtion
Myelodysplasia is reported frequently in HIV/
AIDS patients throughout the spectrum of the 
disease and is thought to be partly responsible for 
anaemia, neutropenia and thrombocytopenia (1, 2, 
3). However the frequency and type of cell line with 
myelodysplastic features appear to differ with stage 
of HIV/AIDS disease and population settings (8). This 
difference in pattern is difficult to explain but appears 
to be multifactorial with factors like level of viral load, 
CD 4 bearing cells, nutritional deficiencies, drugs used 
in the treatment of opportunistic infections and anti-
retroviral drugs plus possibly opportunistic infections 
(4). Hence, this study was aimed at documenting 
the myelodysplastic features of bone marrow at the 
terminal stage of HIV/AIDS in a Ugandan African 
population. 
MateRials and Methods
The study was carried out in the Department of 
Pathology, Faculty of Medicine, Makerere University 
between 2005 and 2006.  Fifty consecutive patients who 
died of natural causes in this study period and were 
HIV seropositive had their bone marrows studied. 
Bone including bone marrow blocks three um thick 
were obtained from sternum, vertebrae and iliac crest, 
fixed in 10% buffered formal saline for a maximum of 
24 hours and then decalcified in formic acid for 6-12 
hours.   These tissues were paraffin embedded and 
sectioned at 4 μ.  These sections were stained with 
haematoxylin and eosin (H&E), Ziehl Neelsen (ZN) 
and periodic acid schifft (PAS) to diagnose infections. 
Myelodysplasia was characterised by abnormal 
maturation as well as architectural arrangement of 
the different cell lines. 
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ResUlts
The 50 cases studied included 26 males and 24 females 
with age ranging from 17 to 57 and mean age of 32 
(SD 8.3) years.  All the 50 cases were severely wasted 
with 18 out 24 females weighing 50kg and below 
while in males, 20 out of 26 weighed below 50 kg. 
Forty-four (88%) had myelodysplasia and of these 21 
were males while 23 were females. Eighteen out of 
the 44 cases had mycobacteria in their bone marrow 
while 15 had cryptococcus neoformans infection in the 
bone marrow.  There was one case of histoplasmosis 
capsulatum infection and two cases with un identifiable 
fungal elements.     
 Table 1 shows age and sex distribution of the three 
cell lineages of dysplasia and there was no statistical 
difference in sex of the various cell lines ( x2 = 0.03, p 
value = 0.87). There was also no significant difference 
between the mean age of the three cell line. (p-value 
= 0.86). 
 Megakaryocytic dysplasia was the most common 
followed by erythroid dysplasia and myelodysplasia. 
Twenty cases had both erythroid myelodysplasia and 
megakaryocytic dysplasia, while only one cell linage 
dysplasia occurred in 24 cases.  Of these 24 cases with 
one cell linage dysplasia, 19 had pure megakaryocytic 
dysplasia, three pure erythroid dysplasia and two 
myelodysplasia. 
 Hypercellularity was a major finding with very 
few cases being hypocellular(12%) and normocellular 
( 14%).
Figure i shows megakaryocytic clustering, nuclear 
hypolobulation of micromegakaryocytes and 
abnormal localisation of megakaryocytes as the only 
dysplastic changes found in the megakaryocytic 
myelodysplasia.  In the erythroid series binucleated 
normoblasts (fig ii) were found in 22cases and only 
one case had erythroid megaloblasts.  Cytoplasmic 
vacuolation was the only dysplastic change found in 
the two granulocytic myelodysplastic cell series.
table 1
Age and sex distribution of cases with myelodysplasia
Cell type    Megakaryocyte     Combined megakaryocytes     Erythroid       Granulocyte                             
                                   and erythroids                  
No of cases    19                20                   3 2
M:F 9:10               10:10 2:1  0:2                          
Mean age 32 (SD 8.45) 31.7 (SD 9.96) 28.5(SD 5.65)  26.5 (SD 4.95)   
Figure i
Clustering of hypolobulated micromegakarocyte x200
Figure ii
Bone marrow shows hypercellular marrow.  Some of the 
normoblasts are binucleated x 400
disCUssion
The severe weight loss coupled with tuberculosis 
and fungal infections found in our cases qualified 
them to be in terminal stages of HIV/AIDS disease 
and this could probably explain the high prevalence 
of myelodysplasia (5).  Similar findings have been 
reported by Diebold et al (6) who found 91% of 
patients with terminal stage of HIV/AIDS disease 
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with myelodysplasia.    In another study by Marche et 
al (7), myelodysplasia was found in 74.4% of the 125 
patients studied at different stages of HIV infection 
and frequency was related to the severity of the 
infection. However Tripathi et al (8) did not show any 
correlation between HIV RNA load and the occurrence 
of myelodysplasia and this was thought to be due to 
the small numbers of cases studied.  
Hypercellularity of bone marrow was  a frequent 
finding.  Previous reports indicate that most cases 
with HIV have hypercellular bone marrow (9).  This 
was also observed in the study of Spivak et al (3) in 
which it was found five out twelve patients with 
severe HIV disease had hypercellular marrow.    The 
hypercellularity observed in this study was mainly 
associated with increasing number of abnormal 
megakaryocyte and to large extent erthryoid cell 
lines.   Khalil et al (10) also reported similar findings 
when they studied 18 patients with HIV infection 
and found 72% had hypercellularity mainly due to 
megakaryocytic hyperplasia.  Similarly Delacrelaz 
et al (11) reported dysmegakaryocytopoiesis and 
dyserthropoiesis in 88% and 83% of the 18 patients 
studied.  Bello et al (12) found abnormal maturation 
more prominent in megakaryocyte but unlike in the 
present study, abnormal granulocyte maturation was 
also prominent.  On the other hand in the study of 
Tripath et al (8) the most commonly affected cell line 
was granulocytic followed by erthyroid. Schneider 
and Picker (1)  also found   granulocytic myelodysplasia 
more frequent although the degree of dysplasia was 
more severe in the megakaryocytic series.  
 In addition to the quantitative changes observed 
in this study, morphological cellular changes were 
also noted.  The megakaryocytic series had the 
most striking changes including clustering of the 
megakaryocytes, a tendency often associated with 
myeloproliferative disorders. Other qualitative 
changes observed in the megakaryocyte series were 
micromegakaryocyte, hypolobulation of nuclei and 
abnormal localisation of megakaryocytes, features 
similar to those reported in pre-leukemic syndrome. 
In the erthryoid series the binucleated erythroblasts 
observed mainly in this study also were suggestive of 
hypoerthryopoiesis and would rule out the possibility 
of nutrition and drugs as causative factors.  This was 
exemplified by the study of Karcher and Frost (13) who 
did not find any association between myelodysplasia 
and anti-retroviral drugs.  Cytoplasmic vacuolation 
found in the only two granulocytic cell series has been 
reported by Tripathi et al (8) as the most important 
dysplastic change and accounted for 60% of the 
dysplastic changes in the granulocytes in their study. 
The pattern of involvement of different cell lines with 
megakaryocyte and erythrocyte being more frequently 
involved as observed in the present study would 
suggest a hypothesis similar to that brought forward 
by Linman and Bagby (14) concerning the evolution 
of pre-leukemic syndrome in which myelodysplastic 
changes affected erythrocytes initially, followed by 
platelets and lastly granulocytic series.  This same 
argument had earlier been reported by Koeffler and 
Golde (15) who also found that there was erythroid 
hyperplasia and megablastoid features which were 
accompanied by micromegakarocytes in pre-leukemic 
syndrome. However Katsarou et al (16) were able to 
differentiate between myelodysplastic syndrome and 
HIV related myelodysplasia by finding abnormal 
karyotype in the latter.  It has also been observed 
that CD34 + human haematopoietic progenitor are 
substantially not susceptible to HIV infection in 
either vitro or vivo and therefore their defects seem 
rather related to the alteration of bone marrow and 
peripheral blood microenvironments probably due to 
the presence of soluble HIV specific products rather 
than direct effect of the virus on the stem cell (17). 
More studies have demonstrated reduced colony 
growth factors for the haematopoietic progenitor 
cells in most patients with AIDS and the cause of 
the reduction of these factors need to be investigated 
(18) (Leiderman et al 1987). In support of the above 
theories in our study population, acute leukemia was 
not observed and there is no evidence that HIV/AIDS 
patients in this African population are at a high risk 
of developing acute leukemia (19). 
 
In conclusion, myelodysplastic features are common 
in HIV patients with megakaryocytic and erythroid 
cell lines being the most affected .This could be due 
to the direct HIV  effect, or the combined effect of 
opportunistic infections, neoplasms ,drugs and HIV 
itself affecting the haemopoietic stem cell and or its 
microenvironment, but this needs to be elucidated 
in further studies.
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